Psoriatic arthritis as a distinct disease entity

Area of Science:

• Rheumatology
• Immunology
• Dermatology

Background:

• Psoriatic arthritis (PsA) is a chronic inflammatory disease linked to psoriasis.
• Historically, PsA received less research attention than other arthropathies.
• Advances in understanding pathogenesis now recognize PsA as a distinct entity.

Purpose of the Study:

• To highlight the distinct features of psoriatic arthritis.
• To review recent therapeutic advances, particularly anti-TNF therapy.
• To discuss the potential of biologic agents for unmet needs in PsA.

Main Methods:

• Review of current understanding of PsA pathogenesis.
• Analysis of clinical and radiological features of PsA.
• Evaluation of efficacy data for anti-TNF therapy and other biologics.

Main Results:

• PsA commonly presents with asymmetric oligoarticular, distal interphalangeal, and spinal involvement.
• Enthesitis and dactylitis are frequent, alongside radiological findings like ankylosis and bone resorption.
• Anti-TNF therapy demonstrates significant efficacy in managing both joint and skin manifestations, improving quality of life and inhibiting radiological progression.

Conclusions:

• Psoriatic arthritis is a unique systemic inflammatory condition.
• Emerging biologic therapies, including anti-TNF agents, offer significant benefits for patients.
• Further research and clinical focus are warranted to address unmet needs in PsA management.